Tcng

TCNG The Cancer Network Galaxy0.14

Database of Cancer Gene Networks from Public Gene Expression Data


Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565

Edge

ELOVL1 → EIF4EBP1

Parent NodeELOVL1
Genes in Parent NodeELOVL1
Child NodeEIF4EBP1
Genes in Child NodeEIF4EBP1

Networks Including this Edge

GSE10780_egf1520 - GSE10780 - SiGN-BN HC+BootstrapProliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
GSE13168_egf1520 - GSE13168 - SiGN-BN HC+BootstrapEffects of glucocorticoids and Protein Kinase A on growth factor- and 1beta- regulated gene
GSE13255_egf1520 - GSE13255 - SiGN-BN HC+BootstrapGene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with NonSmall Cell Lung Cancer.
GSE15459_egf1520 - GSE15459 - SiGN-BN HC+BootstrapGastric Cancer Project '08 (Singapore Patient Cohort)
GSE17372_egf1520 - GSE17372 - SiGN-BN HC+BootstrapMolecular Classification of AIDS-Related Lymphomas [including third-party data]
GSE17705_egf1520 - GSE17705 - SiGN-BN HC+BootstrapEndocrine Sensitivity Index Validation Dataset
GSE17920_egf1520 - GSE17920 - SiGN-BN HC+BootstrapExpression data of diagnostic biopsy samples from Hodgkin lymphoma patients
GSE19069_egf1520 - GSE19069 - SiGN-BN HC+BootstrapMolecular signatures in peripheral T-cell lymphoma (PTCL)
GSE20194_egf1520 - GSE20194 - SiGN-BN HC+BootstrapMAQC-II Project: human breast cancer (BR) data set
GSE22093_egf1520 - GSE22093 - SiGN-BN HC+BootstrapExpression data from breast cancer FNA biopsies from patients
GSE24185_egf1520 - GSE24185 - SiGN-BN HC+BootstrapGene transcription signature of obesity in breast cancer
GSE6764_egf1520 - GSE6764 - SiGN-BN HC+BootstrapGenome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
GSE7390_egf1520 - GSE7390 - SiGN-BN HC+BootstrapStrong Time Dependence of the 76-Gene Prognostic Signature
GSE9195_egf1520 - GSE9195 - SiGN-BN HC+BootstrapPredicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen